We are pleased to announce that we have invested in ScanTech AI Systems Inc. (“ScanTech AI” or the “Company”) (Nasdaq: STAI), a developer of advanced AI-powered security screening and imaging systems. ScanTech AI today announced it has entered into a Purchase Agreement establishing an equity line of credit (“Synthetic ATM”) of up to USD 50 […]

ARC Group, a leading global investment bank specializing in cross-border transactions and capital markets advisory, is pleased to announce that it acted as the exclusive financial advisor on the merger transaction between Titan Pharmaceuticals, Inc. (“Titan” or “TTNP”) and TalenTec Sdn. Bhd. (“TalenTec”), resulting in Black Titan Corporation (“Black Titan” or “BTTC”) as the parent […]

ARC Group participated in the “Enterprise Brand Globalization Service Day” in Longgang District, Shenzhen. The event, themed “Sailing Global, Charted with Quality,” convened more than 150 representatives from international business organizations across Thailand, Malaysia, Singapore, and Italy, alongside leading industry associations and enterprises spanning new energy, medical devices, smart terminals, and advanced manufacturing. Xi Zhang, […]

ARC Group, a leading global investment banking and management consultancy firm, successfully hosted the Capital Markets & M&A Forum Shenzhen 2025 at the Mandarin Oriental Hotel, marking its 10th anniversary and reaffirming its commitment to fostering cross-border investment, financial innovation, and collaboration in one of China’s most dynamic financial hubs. The event brought together 230  […]

ARC Group is pleased to announce that its wholly owned subsidiary, ARC Group Securities LLC (“ARC Securities”), a U.S.-registered, FINRA-member broker-dealer with firm commitment underwriting capabilities, has been approved as an underwriting member of Nasdaq, one of the world’s most prominent securities exchanges. This achievement marks another significant milestone in ARC Group’s mission to provide […]

ARC Group Securities LLC (“ARC Securities”), a wholly owned subsidiary of ARC Group, is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to operate as a registered underwriting broker-dealer in the United States. This milestone marks a significant step in ARC Securities’ ongoing expansion of its global capital […]

We are pleased to announce that ARC Group has been appointed as the exclusive financial advisor to XRP Healthcare M&A Holding Inc. (“XRP”), a corporation organized under the laws of the Abu Dhabi Global Markets (ADGM), in connection with its definitive agreement for a proposed business combination with AAJ Capital 3 Corp. (TSXV: AAAJ.P) (“AAJ”), […]

Following last week’s announcement of being named one of the Best Workplaces™ in Hong Kong 2025, ARC Group proudly joined the official awards ceremony hosted by Great Place To Work Greater China at Maggie Choo’s on July 10. Valentin Ischer, Managing Director at ARC Group, attended the celebration to represent the firm and share reflections […]

ARC Group is proud to announce that we have been recognised as one of the Best Workplaces ™ in Hong Kong 2025 by Great Place To Work™. This distinguished award underscores our dedication to fostering a workplace culture where all employees feel valued, respected, and empowered to thrive; and one with exceptional practices For All […]

ARC Group marked another significant milestone last week with the official opening of its new Hong Kong office, located in the heart of Central at 162 Queen’s Road Central. Situated on the 5th floor of the On Building, this new office underscores ARC Group’s continued growth and its strategic commitment to strengthening its presence in […]

The Capital Markets High Tea 2025 in Ho Chi Minh City brought together key voices from Vietnam’s financial and business community for a curated afternoon of insight, dialogue, and cross-border strategy. Hosted by ARC Group at the elegant MGallery in District 3, the event welcomed company founders, legal advisors, investors, and executives exploring international listing […]

We are pleased to announce our strategic partnership with Meey Land Group Corporation (Meey Group), a pioneering force in Vietnam’s proptech sector, as they prepare for a potential IPO in the United States. ARC Group, a leading global mid-market investment bank and financial advisory firm, will serve as Meey Group’s exclusive financial advisor, guiding the […]

XRP Healthcare M&A Holding Inc. (“XRP Healthcare”), a UAE-based healthcare consolidation and diagnostics platform, has entered into a non-binding letter of intent (LOI) with AAJ Capital 3 Corp. (“AAJ”) (TSXV: AAAJ.P), a Canadian capital pool company. The proposed reverse takeover transaction would constitute AAJ’s Qualifying Transaction under TSX Venture Exchange (the “Exchange”) Policy 2.4. Upon […]

We are pleased to announce that Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) has entered into a definitive share exchange agreement with fitters Sdn. Bhd., a wholly owned subsidiary of FITTERS Diversified Berhad  (9318.KL; “FITTERS”) for a proposed business combination. The transaction, if completed, will result in fitters Sdn. Bhd. becoming a wholly owned subsidiary […]

D. Boral and ARC Group Further Strengthen SPAC Leadership and Global Presence with a Series of SPAC IPOs Beginning in 2025 NEW YORK – May 5, 2025 – D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, and ARC Group, a leading global investment bank and management consultancy firm, are […]

The Capital Markets & M&A Forum 2025: Malaysia Edition, hosted by ARC Group at the esteemed Equatorial Plaza, marked a major milestone as the firm celebrated its 10th anniversary. The event brought together over 400 distinguished guests, including senior executives, investors, legal and advisory professionals, and entrepreneurs—reinforcing ARC Group’s commitment to connecting global capital with […]

We are pleased to announce that BeLive Holdings, a Singapore-based provider of live commerce and shoppable short video solutions, has successfully priced its initial public offering on the Nasdaq Capital Market under the ticker symbol “BLIV.” . The offering consisted of 2,450,000 ordinary shares at a price of US$4.00 per share, resulting in gross proceeds […]

ARC Group is pleased to announce that Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, CYCCP), a clinical-stage biopharmaceutical company, has successfully completed a $1 million private placement offering of its convertible Series E Preferred Stock to accredited investors. The transaction closed on March 21, 2025, and was conducted without the involvement of a placement agent, broker, or […]

At ARC Group, we believe that our greatest achievements are powered by our people. Behind every milestone and success story is a team that collaborates, supports, and grows together. With colleagues from 22 different nationalities, our strength lies in the diversity of our global team and the connections we build across borders. This year’s team-building […]

We are pleased to announce that Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, CYCCP) has completed a successful share purchase and change in control, marking a significant milestone for the company as it transitions leadership and charts a new path forward. ARC Group assisted in facilitating the sale of 70% of Cyclacel’s issued and outstanding shares to […]

ARC Group, a leading global investment banking and management consultancy firm, successfully hosted the Capital Markets & M&A Forum Shanghai 2025 at the Shangri-La Hotel, marking its 10th anniversary and reaffirming its commitment to fostering global investment and financial innovation. The milestone event brought together industry leaders, institutional investors, and corporate executives to discuss the […]

We are pleased to announce our role as financial advisor to Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, CYCCP) in securing a $25 million Private Investment in Public Equity (PIPE) financing aimed at strengthening its financial position and advancing its oncology drug development pipeline. Cyclacel has entered into a Securities Purchase Agreement with David Lazar, its interim […]